| COR | LOE | RECOMMENDATIONS |
|---|---|---|
| 2a | B-NR | 1. In patients with AF and class III obesity (BMI ≥40 kg/m2), DOACs are reasonable to choose over warfarin for stroke risk reduction.1-5 |
| 2b | C-LD | 2. In patients with AF who have undergone bariatric surgery, warfarin may be reasonable to choose over DOACs for stroke risk reduction in view of concerns about DOAC drug absorption.6,7 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.